These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 762215)

  • 21. Thermodynamic differences between the binding interaction of nitrobenzylthioinosine and dipyridamole with the nucleoside transport system of human erythrocytes.
    Clanachan AS; Hammond JR
    Proc West Pharmacol Soc; 1983; 26():251-3. PubMed ID: 6889349
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of dipyridamole on platelet function: correlation with blood levels in man.
    Rajah SM; Crow MJ; Penny AF; Ahmad R; Watson DA
    Br J Clin Pharmacol; 1977 Apr; 4(2):129-33. PubMed ID: 861128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detection of dipiridamol in biological fluids].
    Shormanov VK; Kvachakhia LL; Siplivaia LE
    Sud Med Ekspert; 2007; 50(4):32-5. PubMed ID: 17718088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dipyridamole and 8-aminoguanosine inhibition of nucleoside metabolism in rat blood in vitro.
    Gilbertsen RB; Dong MK
    Adv Exp Med Biol; 1986; 195 Pt A():575-82. PubMed ID: 3088923
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulation of cytarabine uptake and toxicity by dipyridamole.
    King ME; Naporn A; Young B; Howell SB
    Cancer Treat Rep; 1984 Feb; 68(2):361-6. PubMed ID: 6697325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Decomposition and stabilization of drugs. XX. Photodecomposition and stabilization of dipyridamol].
    Kigasawa K; Shimizu H; Hayashida S; Ohkubo K
    Yakugaku Zasshi; 1984 Nov; 104(11):1191-7. PubMed ID: 6530662
    [No Abstract]   [Full Text] [Related]  

  • 27. Interference in fluorescence/nephelometry assays by dipyridamole.
    Wiener K
    Lancet; 1981 Sep; 2(8247):634. PubMed ID: 6116108
    [No Abstract]   [Full Text] [Related]  

  • 28. Nucleoside transporter of pig erythrocytes. Kinetic properties, isolation and reaction with nitrobenzylthioinosine and dipyridamole.
    Woffendin C; Plagemann PG
    Biochim Biophys Acta; 1987 Sep; 903(1):18-30. PubMed ID: 3651452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dipyridamole inhibition of adenosine metabolism in human blood.
    Klabunde RE
    Eur J Pharmacol; 1983 Sep; 93(1-2):21-6. PubMed ID: 6628545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation into the crystallization tendency/kinetics of amorphous active pharmaceutical ingredients: A case study with dipyridamole and cinnarizine.
    Baghel S; Cathcart H; Redington W; O'Reilly NJ
    Eur J Pharm Biopharm; 2016 Jul; 104():59-71. PubMed ID: 27108783
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dipyridamole levels in plasma of man and other species.
    Tyce GM; Fuster V; Owen CA
    Res Commun Chem Pathol Pharmacol; 1979 Dec; 26(3):495-508. PubMed ID: 523785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxicokinetics of a dipyridamole (Persantin) intoxication: case report.
    Lagas JS; Wilhelm AJ; Vos RM; van den Dool EJ; van der Heide Y; Huissoon S; Beijnen JH; Brandjes DP
    Hum Exp Toxicol; 2011 Jan; 30(1):74-8. PubMed ID: 20375123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The absolute and relative bioavailability of dipyridamole from different preparations and the in vitro-in vivo comparison.
    Terhaag B; Donath F; Le Petit G; Feller K
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):298-302. PubMed ID: 3733279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Purine metabolism and clinical status of patients with rheumatoid arthritis treated with dipyridamole.
    Forrest CM; Stone TW; Mackay GM; Oxford L; Stoy N; Harman G; Darlington LG
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):1287-90. PubMed ID: 17065108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectrofluorimetric assessment of plasma dipyridamole stability: sample storage for multicenter clinical trials?
    Serebruany V; Pokov I; Hanley D
    Thromb Res; 2008; 123(1):184-6. PubMed ID: 18691742
    [No Abstract]   [Full Text] [Related]  

  • 36. [Specific binding of dipyridamol on human serum protein. Isolation, identification and characterization as alpha-1-acidic glycoprotein].
    Kopitar Z; Weisenberger H
    Arzneimittelforschung; 1971 Jun; 21(6):859-62. PubMed ID: 5109277
    [No Abstract]   [Full Text] [Related]  

  • 37. Nitrobenzylthioinosine-sensitive nucleoside transport system: mechanism of inhibition by dipyridamole.
    Jarvis SM
    Mol Pharmacol; 1986 Dec; 30(6):659-65. PubMed ID: 3785142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interference of dipyridamole in the analysis of porphyrins by HPLC.
    van Pelt J; Verheesen PE; van Oosterhout AG; Beukeveld GJ; Brombacher PJ
    Ann Clin Biochem; 1992 May; 29 ( Pt 3)():347-8. PubMed ID: 1610111
    [No Abstract]   [Full Text] [Related]  

  • 39. Dipyridamole binding to proteins in human plasma and tissue culture media.
    Szebeni J; Weinstein JN
    J Lab Clin Med; 1991 Jun; 117(6):485-92. PubMed ID: 2045716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of baclofen, captopril, diltiazem hydrochloride, dipyridamole, and flecainide acetate in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(18):2179-84. PubMed ID: 8879325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.